Recent scientific studies even suggest that patients taking semaglutide (Ozempic or Wegovy) show a 19-39% reduction in risk for multiple obesity-related cancers, with the strongest evidence for gastrointestinal cancers
PPAR/PGC1 signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders
So when doctors prescribe Ozempic for weight loss, it's considered "off-label"
UCDavis Health (2023) Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10), Diabetes & Metabolism (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials, The Lancet (2019) Management of Hyperglycemia in Type 2 Diabetes, 2018
Rybelsus is an oral medication taken in tablet form
Appeal insurance denials: While pursuing self-pay options, simultaneously appeal coverage denials with your insurance company